tirzepatide vs tesofensine for Weight Loss Tesofensine Dosing: 0.5mg/Day Community Protocol

Consistent with the lower weight reduction, for each categorical weight reduction target, there was a smaller proportion of late responders who achieved the target compared to early responders

The combination produces superior weight loss outcomes compared to either pathway alone

24.2% at 48 weeks in Phase 2 Tirzepatide : Up to 20.9% body weight reduction (SURMOUNT trials) Advantage : Retatrutide Regulatory Status# Retatrutide : Phase 1-3 clinical trials

Internal Medicine Internal Medicine physician with 30+ years focused on metabolic health, GLP-1 weight loss, and obesity management

What is the best alternative to tirzepatide